LIN-2003

N/A

Report date: 2023/12/20 10:32:26

Base Information

Drug NameLIN-2003
Drug Alias NameLIN-2003
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of Actionα-Galactosidase stimulantsEnzyme replacements
TargetsCerebroside-sulfatase
Therapy Area/IndicationsLeukodystrophy, Metachromatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesLinnuo (Shanghai) Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLinnuo (Shanghai) Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsLeukodystrophy, Metachromatic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A